Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review - Poll - MDSpire

Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review

  • By

  • Luis Cabezón-Gutiérrez

  • Magda Palka-Kotlowska

  • Sara Custodio-Cabello

  • Adriana Carolina Rosero-Rodriguez

  • Beatriz Chacón-Ovejero

  • July 2, 2026

  • 0 min

Share

Original Source(s)

Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review

  • by Luis Cabezón-Gutiérrez, Magda Palka-Kotlowska, Sara Custodio-Cabello, Adriana Carolina Rosero-Rodriguez, Beatriz Chacón-Ovejero

  • July 2, 2026

Related Content

Development and internal validation of a prognostic nomogram incorporating F-NLR and HAGR scores in patients with oral squamous cell carcinoma: a single-center retrospective cohort study

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer

Smartphones Spot Ocular Malignancies

Could a smartphone-based AI system bring ocular oncology screening directly into the patient’s home?

  • July 2, 2026

  • 3 min